Detection of Circulating Hepatoma D23 Antigen and Immune Complexes in Tumour Bearer Serum

Suggestive Evidence That the “Blocking Antibodies” of Tumor-Bearing Individuals May Be Antigen-Antibody Complexes

1971 • 691 citations

Studies on cellular immunity and its serum‐mediated inhibition in moloney‐virus‐induced mouse sarcomas

1969 • 316 citations

Blocking of Lymphocyte-mediated Cytotoxicity for Rat Hepatoma Cells by Tumour-specific Antigen-Antibody Complexes

1972 • 295 citations

Serum Mediated Inhibition of the Immunological Reactions of the Patient to his Own Tumour: A Possible Role for Circulating Antigen

1972 • 289 citations

Elution of “blocking factors” from human tumors, capable of abrogating tumor‐cell destruction by specifically immune lymphocytes

1972 • 190 citations

Inhibition of hepatoma‐immune lymph‐node cell cytotoxicity by tumour‐bearer serum, and solubilized hepatoma antigen

1973 • 157 citations

Cellular and humoral immunity to rat hepatoma‐specific antigens correlated with tumour status

1973 • 91 citations

Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions

1973 • 89 citations

The Presence of Tumour Specific Membrane Antigen in the Serum of Rats with Chemically Induced Sarcomata

1973 • 89 citations

Demonstration of tumour-specific humoral antibody against aminoazo dye-induced rat hepatomata.

1967 • 83 citations

Fractionation of plasma membrane‐associated tumour‐specific antigen from an aminoazo dye‐induced rat hepatoma

1973 • 57 citations

Solubilization of tumour-specific antigen from plasma membrane of an aminoazo-dye-induced rat hepatoma.

1972 • 46 citations